Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Escherichia coli | 7 | 2022 | 1031 | 1.080 |
Why?
|
| PPAR gamma | 7 | 2020 | 89 | 1.030 |
Why?
|
| beta-Lactamases | 3 | 2009 | 212 | 0.750 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2022 | 384 | 0.670 |
Why?
|
| Amino Acid Substitution | 2 | 2014 | 417 | 0.660 |
Why?
|
| Escherichia coli Proteins | 1 | 2022 | 316 | 0.640 |
Why?
|
| Hypertension, Pulmonary | 4 | 2023 | 474 | 0.560 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 2653 | 0.560 |
Why?
|
| Biphenyl Compounds | 2 | 2015 | 63 | 0.490 |
Why?
|
| Homeostasis | 2 | 2019 | 748 | 0.480 |
Why?
|
| Osteogenesis | 2 | 2015 | 168 | 0.450 |
Why?
|
| Osteoblasts | 1 | 2015 | 166 | 0.430 |
Why?
|
| Indoles | 1 | 2015 | 202 | 0.430 |
Why?
|
| Bacterial Proteins | 8 | 2014 | 924 | 0.420 |
Why?
|
| Hypoglycemic Agents | 2 | 2015 | 492 | 0.420 |
Why?
|
| Biological Evolution | 1 | 2014 | 256 | 0.400 |
Why?
|
| Bone and Bones | 1 | 2015 | 311 | 0.400 |
Why?
|
| Mutant Proteins | 2 | 2009 | 120 | 0.380 |
Why?
|
| Pulmonary Artery | 5 | 2023 | 466 | 0.380 |
Why?
|
| Endogenous Retroviruses | 2 | 2022 | 20 | 0.380 |
Why?
|
| Mutation | 7 | 2022 | 6350 | 0.370 |
Why?
|
| Suppression, Genetic | 2 | 2008 | 43 | 0.370 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 1757 | 0.360 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2575 | 0.330 |
Why?
|
| Endothelial Cells | 4 | 2023 | 539 | 0.330 |
Why?
|
| Catalytic Domain | 1 | 2009 | 181 | 0.300 |
Why?
|
| Proline | 1 | 2008 | 81 | 0.290 |
Why?
|
| Serratia marcescens | 1 | 2007 | 11 | 0.270 |
Why?
|
| Cell Differentiation | 1 | 2015 | 2029 | 0.270 |
Why?
|
| Leucine | 1 | 2008 | 312 | 0.270 |
Why?
|
| Arginine | 1 | 2009 | 350 | 0.270 |
Why?
|
| Imidazoles | 2 | 2020 | 219 | 0.260 |
Why?
|
| Piperazines | 2 | 2020 | 256 | 0.260 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2020 | 793 | 0.220 |
Why?
|
| Crystallography, X-Ray | 8 | 2017 | 393 | 0.220 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2022 | 835 | 0.210 |
Why?
|
| Serine Endopeptidases | 3 | 2014 | 199 | 0.210 |
Why?
|
| Mitochondrial Dynamics | 1 | 2024 | 55 | 0.200 |
Why?
|
| Protein Conformation | 6 | 2017 | 873 | 0.200 |
Why?
|
| RNA, Small Untranslated | 1 | 2022 | 21 | 0.190 |
Why?
|
| Colistin | 1 | 2022 | 33 | 0.190 |
Why?
|
| Models, Molecular | 8 | 2017 | 1147 | 0.190 |
Why?
|
| Ciprofloxacin | 1 | 2022 | 69 | 0.190 |
Why?
|
| Vascular Diseases | 1 | 2023 | 156 | 0.180 |
Why?
|
| Pyrophosphatases | 1 | 2021 | 22 | 0.180 |
Why?
|
| DNA Repair | 2 | 2019 | 638 | 0.180 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2020 | 20 | 0.170 |
Why?
|
| Selection, Genetic | 2 | 2014 | 169 | 0.170 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 249 | 0.160 |
Why?
|
| Periplasmic Proteins | 2 | 2010 | 6 | 0.160 |
Why?
|
| Retinoid X Receptor alpha | 2 | 2017 | 20 | 0.160 |
Why?
|
| Neovascularization, Physiologic | 1 | 2020 | 225 | 0.160 |
Why?
|
| Proteins | 3 | 2014 | 1099 | 0.150 |
Why?
|
| Monocytes | 1 | 2021 | 346 | 0.150 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2018 | 34 | 0.150 |
Why?
|
| Sequence Analysis, Protein | 3 | 2013 | 49 | 0.150 |
Why?
|
| Viral Vaccines | 1 | 2021 | 345 | 0.150 |
Why?
|
| HEK293 Cells | 3 | 2019 | 824 | 0.150 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2018 | 20 | 0.150 |
Why?
|
| Molecular Sequence Data | 8 | 2012 | 3966 | 0.150 |
Why?
|
| Regeneration | 1 | 2020 | 228 | 0.140 |
Why?
|
| DNA | 2 | 2017 | 1683 | 0.140 |
Why?
|
| Molecular Docking Simulation | 1 | 2018 | 127 | 0.140 |
Why?
|
| 3T3-L1 Cells | 2 | 2015 | 58 | 0.140 |
Why?
|
| Crystallography | 2 | 2015 | 40 | 0.140 |
Why?
|
| Oncogene Protein tpr-met | 1 | 2017 | 1 | 0.140 |
Why?
|
| Transcription Factors | 2 | 2019 | 2730 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2015 | 306 | 0.130 |
Why?
|
| Deuterium Exchange Measurement | 2 | 2017 | 8 | 0.130 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 638 | 0.130 |
Why?
|
| Kinetics | 2 | 2009 | 1323 | 0.130 |
Why?
|
| Macrophages | 1 | 2021 | 697 | 0.130 |
Why?
|
| Plasmids | 2 | 2008 | 531 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 219 | 0.130 |
Why?
|
| Binding Sites | 5 | 2018 | 1379 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 393 | 0.120 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2017 | 207 | 0.120 |
Why?
|
| Gene Editing | 1 | 2018 | 213 | 0.120 |
Why?
|
| Phosphorylation | 3 | 2015 | 1707 | 0.120 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 298 | 0.120 |
Why?
|
| Models, Genetic | 2 | 2018 | 789 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2010 | 670 | 0.110 |
Why?
|
| Adipogenesis | 1 | 2015 | 82 | 0.110 |
Why?
|
| Protein Binding | 5 | 2019 | 1853 | 0.110 |
Why?
|
| Mice | 8 | 2023 | 18936 | 0.110 |
Why?
|
| Ligands | 4 | 2018 | 571 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 94 | 0.110 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 367 | 0.110 |
Why?
|
| Amino Acid Sequence | 7 | 2012 | 2785 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 400 | 0.100 |
Why?
|
| Familial Primary Pulmonary Hypertension | 2 | 2023 | 22 | 0.100 |
Why?
|
| Feedback | 1 | 2014 | 172 | 0.100 |
Why?
|
| Oxidative Stress | 3 | 2024 | 870 | 0.100 |
Why?
|
| Signal Transduction | 4 | 2021 | 4922 | 0.100 |
Why?
|
| Evolution, Molecular | 3 | 2013 | 710 | 0.100 |
Why?
|
| Animals | 10 | 2023 | 36222 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2011 | 329 | 0.100 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 2 | 2023 | 15 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 1430 | 0.090 |
Why?
|
| Protein Structure, Quaternary | 2 | 2009 | 102 | 0.090 |
Why?
|
| Sequence Alignment | 5 | 2012 | 631 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2011 | 11 | 0.090 |
Why?
|
| Rec A Recombinases | 1 | 2011 | 26 | 0.090 |
Why?
|
| DNA, Bacterial | 2 | 2018 | 491 | 0.090 |
Why?
|
| Protein Structure, Secondary | 2 | 2009 | 256 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 469 | 0.090 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2010 | 16 | 0.090 |
Why?
|
| Thermotoga maritima | 1 | 2010 | 1 | 0.080 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 1036 | 0.080 |
Why?
|
| Exodeoxyribonucleases | 1 | 2010 | 52 | 0.080 |
Why?
|
| Prokaryotic Cells | 1 | 2009 | 8 | 0.080 |
Why?
|
| Bacteroides | 1 | 2010 | 37 | 0.080 |
Why?
|
| Endodeoxyribonucleases | 1 | 2010 | 52 | 0.080 |
Why?
|
| DNA, Single-Stranded | 1 | 2010 | 76 | 0.080 |
Why?
|
| Humans | 18 | 2024 | 133811 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 294 | 0.080 |
Why?
|
| Apoptosis | 2 | 2015 | 1933 | 0.080 |
Why?
|
| Caulobacter crescentus | 1 | 2009 | 3 | 0.080 |
Why?
|
| Phosphotransferases | 1 | 2009 | 41 | 0.080 |
Why?
|
| Histidine | 1 | 2009 | 75 | 0.080 |
Why?
|
| Computational Biology | 1 | 2014 | 890 | 0.080 |
Why?
|
| Enzyme Stability | 1 | 2008 | 60 | 0.070 |
Why?
|
| Ampicillin | 1 | 2008 | 57 | 0.070 |
Why?
|
| Microbial Viability | 1 | 2008 | 43 | 0.070 |
Why?
|
| Hydrolysis | 1 | 2008 | 161 | 0.070 |
Why?
|
| Thermodynamics | 1 | 2008 | 146 | 0.070 |
Why?
|
| DNA Damage | 2 | 2023 | 547 | 0.070 |
Why?
|
| Adenosine Triphosphatases | 1 | 2008 | 202 | 0.070 |
Why?
|
| Protein Sorting Signals | 1 | 2007 | 40 | 0.070 |
Why?
|
| Software | 1 | 2012 | 735 | 0.070 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2007 | 51 | 0.070 |
Why?
|
| Neoplasms | 1 | 2022 | 3035 | 0.070 |
Why?
|
| Carbapenems | 1 | 2007 | 43 | 0.070 |
Why?
|
| Phylogeny | 1 | 2009 | 781 | 0.070 |
Why?
|
| Genes, Bacterial | 1 | 2007 | 218 | 0.060 |
Why?
|
| DNA Primers | 1 | 2007 | 671 | 0.060 |
Why?
|
| Proteome | 2 | 2021 | 282 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2010 | 873 | 0.060 |
Why?
|
| Bacteria | 1 | 2009 | 537 | 0.060 |
Why?
|
| Inflammation | 2 | 2024 | 1570 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 3 | 2010 | 787 | 0.050 |
Why?
|
| Vascular Remodeling | 1 | 2023 | 54 | 0.050 |
Why?
|
| Elafin | 1 | 2022 | 2 | 0.050 |
Why?
|
| Vinculin | 1 | 2022 | 7 | 0.050 |
Why?
|
| Leukocyte Elastase | 1 | 2022 | 22 | 0.050 |
Why?
|
| Base Sequence | 1 | 2007 | 3169 | 0.050 |
Why?
|
| Integrins | 1 | 2022 | 100 | 0.050 |
Why?
|
| RNA Polymerase III | 1 | 2022 | 43 | 0.050 |
Why?
|
| CD146 Antigen | 1 | 2021 | 6 | 0.050 |
Why?
|
| Snail Family Transcription Factors | 1 | 2021 | 26 | 0.050 |
Why?
|
| Molecular Sequence Annotation | 2 | 2013 | 163 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 390 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2022 | 432 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 282 | 0.040 |
Why?
|
| Structural Homology, Protein | 2 | 2010 | 27 | 0.040 |
Why?
|
| Neutrophils | 1 | 2022 | 362 | 0.040 |
Why?
|
| Farnesol | 1 | 1999 | 4 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 2177 | 0.040 |
Why?
|
| Salicylates | 1 | 1999 | 47 | 0.040 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 1999 | 15 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2010 | 299 | 0.040 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2019 | 104 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2024 | 815 | 0.040 |
Why?
|
| Chromatin | 1 | 2022 | 617 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2018 | 68 | 0.040 |
Why?
|
| Proteomics | 1 | 2022 | 605 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2019 | 186 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 139 | 0.040 |
Why?
|
| Carbon-13 Magnetic Resonance Spectroscopy | 1 | 2017 | 2 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2018 | 117 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2015 | 1106 | 0.040 |
Why?
|
| Leucine Zippers | 1 | 2017 | 18 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2019 | 248 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2018 | 212 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2022 | 824 | 0.030 |
Why?
|
| Protein Stability | 1 | 2017 | 175 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2017 | 152 | 0.030 |
Why?
|
| Protein Folding | 1 | 2017 | 222 | 0.030 |
Why?
|
| Protein Domains | 1 | 2017 | 260 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2017 | 640 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2023 | 2559 | 0.030 |
Why?
|
| Algorithms | 2 | 2013 | 1736 | 0.030 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2015 | 87 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1573 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 3144 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 3047 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2015 | 911 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2014 | 313 | 0.030 |
Why?
|
| Models, Biological | 1 | 2019 | 1532 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2013 | 103 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 721 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 886 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2020 | 3979 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 1999 | 907 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2011 | 42 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2011 | 75 | 0.020 |
Why?
|
| Body Fluids | 1 | 2011 | 49 | 0.020 |
Why?
|
| Homologous Recombination | 1 | 2011 | 100 | 0.020 |
Why?
|
| COS Cells | 1 | 2011 | 286 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2012 | 168 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 86 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 150 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2011 | 93 | 0.020 |
Why?
|
| Static Electricity | 1 | 2010 | 47 | 0.020 |
Why?
|
| Adipocytes | 1 | 2011 | 179 | 0.020 |
Why?
|
| Cell Line | 1 | 2015 | 2861 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2010 | 90 | 0.020 |
Why?
|
| Eukaryotic Cells | 1 | 2009 | 32 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2011 | 300 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 1999 | 1853 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 96 | 0.020 |
Why?
|
| Shewanella | 1 | 2008 | 10 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 686 | 0.020 |
Why?
|
| Weight Gain | 1 | 2011 | 413 | 0.020 |
Why?
|
| Dimerization | 1 | 2008 | 153 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 863 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 280 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1728 | 0.020 |
Why?
|
| Female | 3 | 2020 | 71840 | 0.010 |
Why?
|
| Male | 3 | 2020 | 65939 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 4823 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 4760 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1999 | 74 | 0.010 |
Why?
|
| Obesity | 1 | 2011 | 2445 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1999 | 276 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1999 | 450 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1999 | 178 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1999 | 614 | 0.010 |
Why?
|
| Cell Division | 1 | 1999 | 766 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1999 | 7195 | 0.000 |
Why?
|
| Aged | 1 | 1999 | 21714 | 0.000 |
Why?
|